Pancreatic ductal adenocarcinoma contains an effector and regulatory immune cell infiltrate that is altered by multimodal neoadjuvant treatment.

Pancreatic ductal adenocarcinoma contains an effector and regulatory immune cell infiltrate that is altered by multimodal neoadjuvant treatment.

<h4>Objective</h4>The immune response to pancreatic ductal adenocarcinoma (PDA) may play a role in defining its uniquely aggressive biology; therefore, we sought to clearly define the adaptive immune infiltrate in PDA.<h4>Design</h4>We used immunohistochemistry and flow cytom...

Full description

Bibliographic Details
Main Authors: Kendall C Shibuya, Vikas K Goel, Wei Xiong, Jonathan G Sham, Seth M Pollack, Allison M Leahy, Samuel H Whiting, Matthew M Yeh, Cassian Yee, Stanley R Riddell, Venu G Pillarisetty
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2014-01-01
Series:PLoS ONE
Online Access:https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0096565&type=printable

Internet

https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0096565&type=printable

Similar Items